Global Single-Component Peroxyacetic Acid Disinfectant for Endoscopes Market Strategic Research Report

Scope of the Report

The global Single-Component Peroxyacetic Acid Disinfectant for Endoscopes market size is predicted to grow from US$ 244 million in 2025 to US$ 360 million in 2032; it is expected to grow at a CAGR of 5.5% from 2026 to 2032.

Single-component peracetic acid disinfectant for endoscopes is a high-level disinfectant centered on a stabilized, single-component peracetic acid system. Typically, it does not require the mixing of a primary agent and an activator prior to use; it can be applied directly—or after dilution as required—for the disinfection of flexible endoscopes, rigid endoscopes, and associated accessories. Its key characteristics include a broad spectrum of antimicrobial activity, rapid action, relatively low residual decomposition, suitability for disinfecting endoscope lumens, and compatibility with automated endoscope washer-disinfectors. In 2025, global sales volume is projected to reach approximately 7.8 million liters, with an average unit price of approximately $32 per liter and a capacity utilization rate of approximately 72%. Upstream enterprises primarily consist of suppliers of hydrogen peroxide, glacial acetic acid, stabilizers, corrosion inhibitors, surfactants, purified water, packaging containers, concentration test strips, and hazardous chemical logistics services. Downstream entities mainly comprise hospital digestive endoscopy centers, respiratory endoscopy centers, ENT departments, urological endoscopy centers, clinics, health examination centers, third-party sterile processing organizations, and medical device reprocessing service providers. The gross profit margin stands at approximately 41%. Within the product's cost structure, the active peracetic acid ingredient and precursor raw materials account for 28%; stabilizers and corrosion inhibitors for 15%; surfactants and functional additives for 7%; purified water and solution preparation for 5%; packaging materials for 10%; microbiological validation and quality testing for 9%; regulatory registration and validation documentation for 8%; production labor and energy consumption for 6%; and warehousing, logistics, and miscellaneous costs for 12%. The list of demand drivers includes the need for high-level endoscope disinfection, rapid turnaround disinfection, compatibility with automated endoscope washer-disinfectors, low-corrosion disinfection, low-residue disinfection, concentration monitoring support, hospital infection control, and the standardized development of grassroots-level endoscopy centers. The list of downstream customers encompasses tertiary hospitals, secondary hospitals, digestive endoscopy centers, respiratory endoscopy centers, ENT clinics, urological endoscopy units, health examination institutions, specialized clinics, sterile processing centers, and medical device reprocessing service providers. In terms of business opportunities, policy-driven factors stem primarily from heightened requirements for hospital infection control, the standardization of endoscope cleaning and disinfection protocols, strengthened medical quality assessment, capacity building for endoscopic diagnosis and treatment at the primary care level, and increasingly stringent regulatory oversight of disinfection products. Technological innovation is driven mainly by advancements in single-component stabilized formulations, low-corrosion and corrosion-inhibiting systems, rapid sterilization processes, compatibility with automated dosing systems, real-time concentration monitoring, low-odor formulations, and traceable packaging labels. Changes in consumer demand—manifested in hospitals placing greater emphasis on operational simplicity, disinfection speed, personnel safety, endoscope protection, residue control, cost-effectiveness, and supply stability—are driving the development of single-component peracetic acid disinfectants for endoscopes toward solutions that are ready-to-use, low-corrosion, low-irritation, machine-compatible, and backed by robust regulatory documentation.

Global key Single-Component Peroxyacetic Acid Disinfectant for Endoscopes players cover Fujifilm (JP), Steris Life Sciences (US), Olympus (JP), Ecolab (US), AMTEC (GB), etc.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Single-Component Peroxyacetic Acid Disinfectant for Endoscopes market?

What factors are driving Single-Component Peroxyacetic Acid Disinfectant for Endoscopes market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Single-Component Peroxyacetic Acid Disinfectant for Endoscopes market opportunities vary by end market size?

How does Single-Component Peroxyacetic Acid Disinfectant for Endoscopes break out by Peracetic Acid Content, by Application?

This report presents a comprehensive overview of the global Single-Component Peroxyacetic Acid Disinfectant for Endoscopes market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Using Type

• Ready-To-Use
• Concentrate

Segment by Peracetic Acid Content

• ＜10%
• 10%-15%
• ＞15%

Segment by Application

• Hospital
• Clinic
• Research Institution
• Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Single-Component Peroxyacetic Acid Disinfectant for Endoscopes market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Hospital, Clinic, Research Institution evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact